These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17311468)

  • 1. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.
    Boutron I; Guittet L; Estellat C; Moher D; Hróbjartsson A; Ravaud P
    PLoS Med; 2007 Feb; 4(2):e61. PubMed ID: 17311468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review.
    Boutron I; Estellat C; Guittet L; Dechartres A; Sackett DL; Hróbjartsson A; Ravaud P
    PLoS Med; 2006 Oct; 3(10):e425. PubMed ID: 17076559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of blinding in randomized controlled trials found results inconsistent and questionable.
    Boutron I; Estellat C; Ravaud P
    J Clin Epidemiol; 2005 Dec; 58(12):1220-6. PubMed ID: 16291465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
    Fergusson D; Glass KC; Waring D; Shapiro S
    BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies.
    Chan S; Bhandari M
    J Bone Joint Surg Am; 2007 Sep; 89(9):1970-8. PubMed ID: 17768194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
    Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
    Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.
    Devereaux PJ; Choi PT; El-Dika S; Bhandari M; Montori VM; Schünemann HJ; Garg AX; Busse JW; Heels-Ansdell D; Ghali WA; Manns BJ; Guyatt GH
    J Clin Epidemiol; 2004 Dec; 57(12):1232-6. PubMed ID: 15617948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quality of reporting and outcome measures in randomized clinical trials related to upper-extremity disorders.
    Gummesson C; Atroshi I; Ekdahl C
    J Hand Surg Am; 2004 Jul; 29(4):727-34; discussion 735-7. PubMed ID: 15249101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritis.
    Boutron I; Tubach F; Giraudeau B; Ravaud P
    JAMA; 2003 Aug; 290(8):1062-70. PubMed ID: 12941679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing quality of reports on randomized clinical trials in nursing journals.
    Parent N; Hanley JA
    Can J Cardiovasc Nurs; 2009; 19(2):25-39. PubMed ID: 19517902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The number, content, and quality of randomized controlled trials in the prevention and care of injuries.
    Stelfox HT; Goverman J
    J Trauma; 2008 Dec; 65(6):1488-93. PubMed ID: 19077647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blinding in randomized clinical trials: imposed impartiality.
    Hróbjartsson A; Boutron I
    Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus.
    Boutron I; Moher D; Tugwell P; Giraudeau B; Poiraudeau S; Nizard R; Ravaud P
    J Clin Epidemiol; 2005 Dec; 58(12):1233-40. PubMed ID: 16291467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
    Miller LE; Stewart ME
    Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blinding terminology used in reports of randomized controlled trials involving dogs and cats.
    Giuffrida MA; Agnello KA; Brown DC
    J Am Vet Med Assoc; 2012 Nov; 241(9):1221-6. PubMed ID: 23078571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.
    Boutron I; Tubach F; Giraudeau B; Ravaud P
    J Clin Epidemiol; 2004 Jun; 57(6):543-50. PubMed ID: 15246122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of bias in randomized controlled trials published in prosthodontic journals.
    Dumbrigue HB; Jones JS; Esquivel JF
    J Prosthet Dent; 2001 Dec; 86(6):592-6. PubMed ID: 11753309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blinding in Surgical Randomized Clinical Trials in 2015.
    Speich B
    Ann Surg; 2017 Jul; 266(1):21-22. PubMed ID: 28350566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid.
    Akl EA; Sun X; Busse JW; Johnston BC; Briel M; Mulla S; You JJ; Bassler D; Lamontagne F; Vera C; Alshurafa M; Katsios CM; Heels-Ansdell D; Zhou Q; Mills E; Guyatt GH
    J Clin Epidemiol; 2012 Mar; 65(3):262-7. PubMed ID: 22200346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.